The impact of an individualized risk-adjusted approach on hypertension treatment in primary care
- PMID: 28058765
- PMCID: PMC8031272
- DOI: 10.1111/jch.12958
The impact of an individualized risk-adjusted approach on hypertension treatment in primary care
Abstract
Previous studies suggest that up to 60% of all patients with hypertension receive inappropriate treatment. Current 2013 European Society of Hypertension/European Society of Cardiology (ESH/ESC) guidelines recommend taking cardiovascular risk factors into account when assessing treatment for patients with hypertension. The authors hypothesize that this approach will reduce the proportion of patients receiving inappropriate treatment. In this cross-sectional study using electronic medical records of Swiss primary care patients, the authors estimate the proportion of patients receiving inappropriate treatment using two approaches: (1) based on a blood pressure threshold of 140/90 mm Hg; and (2) based on cardiovascular risk factors. A total of 22 434 patients with hypertension were identified. Based on these approaches, 72.7% and 44.6% of patients, respectively, qualified for drug treatment. In addition, 23.0% and 10.8% of patients, respectively, received inappropriate treatment. Application of the 2013 ESH/ESC guidelines reduced the proportion of patients receiving inappropriate treatment by 50%. This shows the major impact of risk adjustment and highlights the need for a patient-centered approach in hypertension treatment.
Keywords: antihypertensive therapy; clinical management of high blood pressure; primary care issues; risk assessment; treatment and diagnosis/guidelines.
©2017 Wiley Periodicals, Inc.
Figures




Similar articles
-
Eligibility to treatment and economic effect of the implementation of the new U.S. or European Society of Hypertension/European Society of Cardiology hypertension guidelines.J Hypertens. 2015 Apr;33(4):868-73. doi: 10.1097/HJH.0000000000000466. J Hypertens. 2015. PMID: 25915892
-
ESH-ESC guidelines for the management of hypertension.Herz. 2006 Jun;31(4):331-8. doi: 10.1007/s00059-006-2829-3. Herz. 2006. PMID: 16810473
-
[Initial management of hypertension in a primary care service].Rev Med Suisse. 2006 Sep 13;2(78):2024-6, 2029-34. Rev Med Suisse. 2006. PMID: 17019837 French.
-
What Is New and Different in the 2024 European Society of Cardiology Guidelines for the Management of Elevated Blood Pressure and Hypertension?Hypertension. 2025 Mar;82(3):432-444. doi: 10.1161/HYPERTENSIONAHA.124.24173. Epub 2024 Dec 31. Hypertension. 2025. PMID: 39970254 Review.
-
[European guidelines for the management of arterial hypertension 2018-what has changed?].Internist (Berl). 2019 Feb;60(2):202-208. doi: 10.1007/s00108-018-0552-9. Internist (Berl). 2019. PMID: 30649580 Review. German.
Cited by
-
Medication use and falls: Applying Beers criteria to medication review in Parkinson's disease.SAGE Open Med. 2017 Nov 20;5:2050312117743673. doi: 10.1177/2050312117743673. eCollection 2017. SAGE Open Med. 2017. PMID: 29201368 Free PMC article.
References
-
- WHO . World Health Organisation. World Health Statistics 2015. http://www.who.int/gho/publications/world_health_statistics/2015/en/. ISBN 978 92 4 069443 9 (PDF).
-
- Patel SA, Winkel M, Ali MK, Narayan KM, Mehta NK. Cardiovascular mortality associated with 5 leading risk factors: national and state preventable fractions estimated from survey data. Ann Intern Med. 2015;163:245–253. - PubMed
-
- Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–223. - PubMed
-
- Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159–2219. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical